Explore how Big Pharma's shift to smaller acquisitions is reshaping biotech opportunities and driving innovation. Discover key players and investment insights in this evolving landscape.
Explore the impact of Trump's recent remarks on NATO, energy, and pharmaceuticals. Discover investment opportunities across defense, energy, and healthcare sectors amid geopolitical tensions.
Explore AstraZeneca's latest Form 6-K detailing Tezspire's FDA approval for CRSwNP, clinical trial successes, and market impact. Discover its potential in chronic respiratory care.
AstraZeneca's historic agreement with the U.S. government aims to lower drug prices by up to 80%. The deal includes a $50 billion investment in U.S. manufacturing and R&D, enhancing patient access.